[Form 4] Lifevantage Corporation Insider Trading Activity

Rhea-AI Filing Summary

LifeVantage Corporation (LFVN) Chief Marketing Officer Julie Boyster filed a Form 4 covering transactions on 1 July 2025.

• 3,667 shares acquired through the conversion (code M) of previously granted performance restricted stock units (PSUs) at a $0 exercise price.
• 3,970 shares disposed (code F) to cover statutory tax withholding at $13.39 per share.
• Post-transaction, Boyster directly owns 115,214 common shares; all PSUs from the 2022 grant have now been converted.
• The 2022 PSU grant paid out at 133.13 % of target, indicating the company exceeded the preset performance criteria.

The net effect is a modest reduction of 303 shares (-0.3 % of her holdings). Because both events are routine vesting and tax-withholding activities, they carry limited market impact but do confirm above-target performance achievement for the FY-2022 incentive metrics.

Positive

• Performance goals exceeded: 2022 PSU payout at 133.13 % of target confirms above-target achievement of preset financial criteria.

Negative

• Minor net share reduction: Insider’s direct holdings decreased by 303 shares after tax withholding, though the change is immaterial.

Insights

Securities Analyst

TL;DR Routine PSU vesting; company beat performance hurdles; negligible change in insider ownership and minimal market impact.

The Form 4 shows standard quarterly vesting of 2022 PSUs. Conversion of 3,667 units at no cost and immediate share withholding of 3,970 shares for taxes reduced Boyster’s direct stake by only 303 shares, leaving her with 115,214 shares. The standout detail is that the 2022 award vested at 133.13 % of target, confirming that LifeVantage surpassed the financial KPIs embedded in that plan. While a positive signal on prior-period performance execution, the transaction is administrative and does not introduce new forward-looking information. I view the filing as neutral to the share price outlook.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Kristen

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		M		3,001(1)	A	$0	107,389	D
Common Stock	07/01/2025		F		3,387	D	$13.39	104,002	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Restricted Stock Units	(2)	07/01/2025		M			3,001	(1)	(1)	Common Stock	3,001	$0	0	D

Explanation of Responses:

1. On August 18, 2022, the Reporting Person was granted PSUs which vest only to the extent specified financial performance criteria are achieved and subject to the Reporting Person's continued service with the Issuer, as follows: (i) 1/3 of the earned award vested on the first anniversary of the grant date and (ii) an additional 1/12 of the earned award will vest on the first day of each calendar quarter thereafter. The Reporting Person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target; accordingly, the Reporting Person is eligible to earn 133.13% of the target number of units. The actual number of shares that vested on the reported transaction date was 133.13% of the at-target number of shares subject to vesting on that date and the number of PSUs beneficially owned following the reported transaction has been updated to reflect the new target number of units.

2. Performance Restricted Stock Units ("PSUs") convert into common stock on a one-for-one basis.

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Kristen Cunningham	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did LFVN report on 1 July 2025?

The CMO converted 3,667 PSUs into shares and withheld 3,970 shares to cover taxes.

How many LifeVantage shares does Julie Boyster now own?

She directly owns 115,214 common shares after the reported transactions.

What was the vesting performance factor for the 2022 PSUs?

The PSUs vested at 133.13 % of the target based on achieved performance metrics.

Did the filing signal any new stock purchases by the insider?

No cash purchases were made; shares were acquired via PSU conversion and partly withheld for taxes.

Is this Form 4 likely to impact LFVN’s stock price?

The filing is routine and immaterial, so material price impact is unlikely.